Eli Lilly
-
healthEli Lilly Acquires Kelonia Therapeutics for Up to $7 Billion in Cancer Therapy Push
Eli Lilly announces a major acquisition of Kelonia Therapeutics for up to $7 billion, bolstering its cell therapy pipeline with a novel in vivo cancer treatment.
-
financeUS Stocks Dip as Inflation Fears Linger Ahead of Key Talks
US stocks faced downward pressure as inflation concerns persisted. Bond yields rose, and consumer sentiment soured amid stubbornly high prices.
-
financeTrump Orders Up to 100% Tariffs on Patented Drugs
President Trump signs executive order imposing tiered tariffs on imported patented drugs, offering exemptions for firms relocating production to the U.S. and negotiating pricing deals.
-
worldTrump Imposes 100% Tariff on Branded Drugs
President Trump announces 100% tariffs on imported patented drugs unless manufacturers comply with new pricing agreements or produce in the U.S.
-
healthFDA Approves First Oral GLP-1 Weight-Loss Pill Foundayo
Foundayo is the latest once-daily pill approved for weight loss, offering flexibility without food or water restrictions.
-
healthEli Lilly’s Orforglipron Wins FDA Approval for Weight Loss
The FDA approved Eli Lilly's once-daily pill for chronic weight management in adults with obesity or related conditions.
-
healthFDA Approves Eli Lilly’s Oral GLP-1 Weight-Loss Pill Foundayo
The FDA has fast-tracked approval of Foundayo, Eli Lilly’s once-daily oral GLP-1 pill for obesity and overweight adults with comorbidities, following rapid clinical results and safety warnings.
-
healthEli Lilly Announces Landmark $2.75 Billion AI Alliance With Insilico Medicine
Eli Lilly forms a strategic partnership with Insilico Medicine valued at up to $2.75 billion. The deal leverages generative AI to significantly accelerate pharmaceutical drug discovery timelines.